News

UnitedHealth Group Incorporated’s UNH new CEO, Steve Hemsley, began his return to leadership by issuing a rare apology to investors following the company’s first earnings miss in almost two decades

Chevron Corporation CVX, the U.S. oil and gas giant, has announced that it will let go of nearly 200 workers in Texas as part of the broader plan to reduce the global workforce by up to 20% by the

The second half of 2025 has kicked off on a cautious note. While U.S. stocks opened June in positive territory, geopolitical tensions, particularly between the United States and China, continue to

Tuesday, June 3, 2025Pre-market futures are mostly flat-to-down this morning, giving back some of the overall modest gains posted in Monday’s session. The Dow is -74 points, -0.17%, the S&P 500 and

Visa Inc. V, a global leader in payment processing, continues to impress with strong financials, rising cross-border volumes, and the growing adoption of digital payments. Resilient consumer

Enterprise Products Partners LP EPD has a strong presence in the Permian Basin, the most prolific basin in the United States, as its customers are primarily large upstream and integrated oil and gas

Defense contractor, RTX Corporation RTX is a prominent forerunner in the missile systems space, with a robust portfolio including the TOW missile, Guidance Enhanced Missile, Advanced Medium Range

Shares of Axon Enterprise, Inc. AXON have been showing impressive gains of late, trading close to its 52-week high of $765.00. The stock closed at $758.57 on Monday, 0.8% below the highest point

Thermo Fisher Scientific Inc. TMO recently launched the Thermo Scientific Orbitrap Astral Zoom mass spectrometer (MS) and the Thermo Scientific Orbitrap Excedion Pro MS at the American Society for

Marriott International, Inc. MAR has marked the debut of its midscale extended stay segment with the exemplary opening of the very first StudioRes hotel, StudioRes Fort Myers, in Florida.Through

After several months of extreme volatility driven by geopolitical uncertainty and shifting tariff policies, bullish momentum has returned to the market. With tariff policy moderating, economic

Tesla’s TSLA car sales dropped significantly in several European countries in May, which marks the fifth straight month of declines. This downturn has been attributed to CEO Elon Musk’s political

Louisiana-Pacific Corporation LPX, a producer of engineered wood building products, expanded its distribution partnership with BlueLinx Holdings to include the market of Springfield, MO. This

Dave & Buster's (PLAY) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook

Wall Street expects a year-over-year decline in earnings on lower revenues when Smucker (SJM) reports results for the quarter ended April 2025. While this widely-known consensus outlook is important

ETFs across various categories pulled in $17 billion in capital last week, pushing year-to-date inflows to $442 billion. This has put 2025 on track to be one of the biggest years ever for ETF

Vail Resorts, Inc. MTN is scheduled to report its third-quarter fiscal 2025 results on June 5, after the closing bell.In the last quarter, its adjusted earnings topped the Zacks Consensus Estimate

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 3rd:

Flotek Industries FTK: This company which develops and delivers prescriptive

Immatics (IMTX) closed the last trading session at $6.01, gaining 17.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Arcosa (ACA) closed the last trading session at $86.33, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Contango ORE, Inc. (CTGO) closed the last trading session at $20.27, gaining 45.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Arcturus Therapeutics (ARCT) have gained 7.5% over the past four weeks to close the last trading session at $12.81, but there could still be a solid upside left in the stock if short-term

Aardvark Therapeutics, Inc. (AARD) closed the last trading session at $11.13, gaining 5.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets